Ticker
MLYSCompany Name
MINERALYS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 335.72M | $ 101.79M | 30.32% |
3/31/2025 | $ 354.94M | $ 165.01M | 46.49% |
12/31/2024 | $ 205.9M | $ 114.09M | 55.41% |
9/30/2024 | $ 268.25M | $ 97.27M | 36.26% |
6/30/2024 | $ 318.49M | $ 67.86M | 21.31% |
3/31/2024 | $ 347.25M | $ 90.42M | 26.04% |
12/31/2023 | $ 251.64M | $ 49.3M | 19.59% |
9/30/2023 | $ 277.56M | $ 86.3M | 31.09% |
6/30/2023 | $ 291.22M | $ 101.14M | 34.73% |
3/31/2023 | $ 306.44M | $ 138.25M | 45.11% |
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for MINERALYS THERAPEUTICS INC is calculated as follows: CashnEq [ $ 10.61M ] / Assets [ $ 11.13M ]
(=) Cash to Assets [ 95.39% ]
Minimum
Dec 31, 2023
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.92% |
average | 9.84% |
median | 6.44% |
std | 9.62% |